XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2025
Summary of Significant Accounting Policies [Abstract]  
Schedule of Translation of Foreign Currencies

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

   As of
March 31,
 
   2025   2024 
Period-average MYR: US$1 exchange rate   4.44    4.72 

 

   For the 
nine months ended
March 31,
 
   2025   2024 
Period-average MYR: US$1 exchange rate   4.43    4.68 
Schedule of Estimated Useful Lives of the Assets

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

 

   Expected
useful lives
Computer and office equipment  5 years
Furniture and fixtures  3-5 years
Motor vehicles  5 years
Leasehold improvement  3 years
Schedule of Disaggregated Information of Revenues by Products/Services

Disaggregated information of revenues by products/services are as follows:

 

   For the 
three months ended
   For the
nine months ended
 
   March 31,   March 31, 
   2025   2024   2025   2024 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Gift card or “E-voucher” revenue (1)  $25,786   $1,213,360   $62,483   $20,083,266 
Health care products, computer products, and food and beverage products revenue (1)   
-
    226,587    296,667    952,853 
Loyalty program revenue (1)   2,808    15,254    19,448    123,071 
Transaction revenue (1)   35,321    13,666    106,879    49,741 
Member subscription revenue (2)   
-
    84,235    87,707    405,659 
Sublicense revenue (2)   
-
    43,027    
-
    159,239 
Total revenues from ZCITY platform   63,915    1,596,129    573,184    21,773,829 
                     
Revenue from Customized software development service (2)   602,606    
-
    602,606    
-
 
Total revenue  $666,521   $1,596,129   $1,175,790   $21,773,829 

 

(1) Revenue recognized at a point in time.

 

(2) Revenue recognized over time.
Schedule of Basic and Diluted Net Income (Loss) Per Common Share

The following table summarizes the calculation of basic and diluted net income (loss) per common share:

 

   For the 
Three Months Ended
 
   March 31, 
   2025   2024 
   (Unaudited)   (Unaudited) 
Net income (loss) attributable to common stock  $1,259,965   $(1,713,315)
           
Basic and diluted earnings per share          
Basic weighted average shares outstanding*   1,156,208    14,766 
Basic and diluted earnings (loss) per share   1.09    (116.03)

 

   For the
 Nine Months Ended
 
   March 31, 
   2025   2024 
   (Unaudited)   (Unaudited) 
Net income (loss) attributable to common stock  $76,926   $(5,044,541)
           
Basic and diluted earnings per share          
Basic weighted average shares outstanding*   542,963    6,886 
Basic and diluted earnings (loss) per share   0.14    (732.60)

 

*For the three months ended March 31, 2025 and 2024, 23,298 and 28 contingent shares to be issued to the investor, underwriters and convertible note holders are excluded in the diluted EPS calculation due to its anti-diluted effect, respectively. For the nine months ended March 31, 2025 and 2024, 23,298 and 28 contingent shares to be issued to the investor, underwriters and convertible note holders are excluded in the diluted EPS calculation due to its anti-diluted effect, respectively.
Schedule of Financial Assets that were Measured at Fair Value on a Recurring Basis

The following table presents information about the Company’s financial asset and liabilities that were measured at fair value on a recurring basis as of March 31, 2025 and June 30, 2024: 

 

   March 31,
2025
   Quoted
Prices in
Active
Market
(Level 1)
   Significant
Other
Observable
Input
(Level 2)
   Significant
Other
Unobservable
Input
(Level 3)
 
                 
Assets:                
Investment in marketable securities  $2,450   $2,450   $
     -
   $
-
 
                     
Liabilities:                    
Derivative liabilities  $431,403   $
-
   $
-
   $431,403 

 

   June 30,
2024
   Quoted
Prices in
Active
Market
(Level 1)
   Significant
Other
Observable
Input
(Level 2)
   Significant
Other
Unobservable
Input
(Level 3)
 
               $ 
Assets:                
Investment in marketable securities  $171,633   $171,633   $
     -
   $
     -
 
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following is a reconciliation of the beginning and ending balance of the assets and liabilities measured at fair value on a recurring basis for the nine months ended March 31, 2025 and for the year ended June 30, 2024:

 

   Warrant issued under Share Purchase Agreement 
Balance as of June 30, 2023  $
-
 
Change in fair value of derivative liabilities   
-
 
Balance as of June 30, 2024   
-
 
Derivative liabilities recognized at grant date   2,213,161 
Change in fair value of derivative liabilities   (1,781,758)
Balance as of March 31, 2025  $431,403